Get started
Author

Ana Caroline Fonseca Alves

Observed names: Ana Alves, Ana Caroline Alves
ORCID: 0009-0003-0274-2796
Observed ORCID: 0009-0003-0274-2796
OpenAlex ID: A5062478890
The roles of PTEN, cMET, and p16 in resistance to cetuximab in head and neck squamous cell carcinoma
2018 · Alexandre A. B. A. da Costa, Felipe D’Almeida Costa, et al. · Medical Oncology · 20
Adjuvant Immunotherapy in High-Risk Muscle-Invasive Urothelial Cancer: An Updated Meta-Analysis of Randomized Controlled Trials
2024 · Isadora Mamede, Caroliny Silva, et al. · Clinical Genitourinary Cancer · 10
Primary Tumor Location Is a Predictor of Poor Prognosis in Patients with Locally Advanced Esophagogastric Cancer Treated with Perioperative Chemotherapy
2019 · Tiago Cordeiro Felismino, Audrey Cabral Ferreira de Oliveira, et al. · Journal of Gastrointestinal Cancer · 8
Immunotherapy Plus Chemotherapy Versus Chemotherapy Alone as First-Line Treatment for Advanced Urothelial Cancer: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
2024 · Isadora Mamede, Lorena Escalante-Romero, et al. · Clinical Genitourinary Cancer · 7
Immune checkpoint inhibitors in clear cell ovarian carcinoma and mixed gynecologic clear cell cohorts: a systematic review and meta-analysis
2026 · Mariana Macambira Noronha, Luiz Felipe Costa de Almeida, et al. · International Journal of Gynecological Cancer · 2
Immunotherapy plus chemotherapy versus chemotherapy alone in perioperative treatment for locally advanced gastric cancer: A systematic review and meta-analysis.
2024 · Isadora Mamede Mendes da Silva, João Pedro Oliveira, et al. · Journal of Clinical Oncology · 2
PDF
PTEN and cetuximab resistance in head and neck squamous cell carcinoma (HNSCC).
2017 · Alexandre Andre B. A. Da Costa, Felipe D'Almeida Costa, et al. · Journal of Clinical Oncology · 2
Brazilian Society of Surgical Oncology: Guidelines and Consensus Statement for Palliative Surgery in Oncology
2026 · Audrey Cabral Ferreira de Oliveira, Jordana Henz Hammes, et al. · Journal of Surgical Oncology · 1
Adjuvant immune checkpoint inhibitors in early-stage non-small cell lung cancer: insights from a systematic review and meta-analysis
2025 · Isadora Mamede, Carlos Stecca, et al. · Clinical & Translational Oncology · 1
Brazilian Society of Surgical Oncology: Realities and challenges of surgical oncologists in palliative care practice.
2025 · Audrey Cabral Ferreira de Oliveira, Isabela Oliva, et al. · Journal of Clinical Oncology · 1
PDF
Chemotherapy plus PD-1/PD-L1 inhibitor versus chemotherapy alone in first-line treatment for recurrent or advanced endometrial cancer: A systematic review and meta-analysis of randomized controlled trials.
2024 · Caio Dabbous de Liz, Melissa Maia, et al. · Journal of Clinical Oncology · 1
Trust, ethics, and patient engagement in clinical research: Findings from the LACOG 1123 ASTRAL survey in Brazil.
2026 · Gisah Guilgen, Debora De Melo Gagliato, et al. · Journal of Clinical Oncology
Trastuzumab (Tmab) plus chemotherapy (CT) vs CT alone in the perioperative treatment of HER2-positive gastric cancer: A systematic review and meta-analysis of randomized controlled trials (RCTs).
2026 · Ana Caroline Fonseca Alves, Rachel Arantes Moraes, et al. · Journal of Clinical Oncology
Efficacy and safety of immune checkpoint inhibitors in clear cell ovarian cancer: A systematic review and meta-analysis of phase II clinical trials
2026 · Mariana Macambira Noronha, Lara De Holanda Juca Silveira, et al. · International Journal of Gynecological Cancer
The distinct molecular profile of metastatic prostate cancer in the mixed Brazilian population
2026 · Gabriel S. Macedo, Jaqueline Bohrer Schuch, et al. · Genetics in Medicine Open
Treatment patterns and survival outcomes in metastatic castration-resistant prostate cancer in the Brazilian population: LACOG 1818.
2025 · Fernando Cotait Maluf, Suelen Patrícia dos Santos Martins, et al. · Journal of Clinical Oncology
PDF
Effectiveness of adjuvant immunotherapy in muscle-invasive urothelial cancer: A systematic review and meta-analysis of randomized controlled trials.
2024 · Isadora Mamede Mendes da Silva, Caroliny Silva, et al. · Journal of Clinical Oncology
Immunotherapy plus chemotherapy versus chemotherapy alone as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis of randomized controlled trials.
2024 · Ana Caroline Fonseca Alves, Isadora Mamede Mendes da Silva, et al. · Journal of Clinical Oncology
PDF
Immune checkpoint inhibitor plus chemotherapy versus chemotherapy alone in HER2-negative advanced gastric or gastroesophageal junction cancer: A systematic review and meta-analysis of randomized controlled trials.
2024 · João Pedro Oliveira, Isadora Mamede Mendes da Silva, et al. · Journal of Clinical Oncology
PDF
Survival outcomes of metastatic castration-resistant prostate cancer in Brazil (LACOG 1818).
2023 · Fernando Cotait Maluf, Suelen P. S. Martins, et al. · Journal of Clinical Oncology
Adjuvant treatment in stage III gastric cancer patients in Brazil and Peru: Results of a retrospective study in two cancer centers in Latin America.
2018 · Jose Eduardo Nunez, Tiago Felismino, et al. · Journal of Clinical Oncology
HER-2 overexpression in gastroesophageal junction (EGJ) adenocarcinoma as a predictor of prognosis in patients treated with perioperative chemotherapy.
2018 · Tiago Felismino, Audrey Oliveira, et al. · Journal of Clinical Oncology
A comparison of doublet versus triplet chemotherapy regimens for esophagogastric adenocarcinoma (EGC): Is more always better?
2018 · Tiago Felismino, Ana Caroline Alves, et al. · Journal of Clinical Oncology
Evaluation of the outcome of adjuvant treatment for gastric cancer in Brazil and Peru: A retrospective study in two cancer centers in Latin America.
2018 · Jose Eduardo Nunez, Tiago Felismino, et al. · Journal of Clinical Oncology
Refratariedade a Regime De Primeira Linha Contendo Oxaliplatina No Tratamento Do Câncer Colorretal Metastático. Análise Retrospectiva Unicêntrica
2017 · Larissa Martins Machado, Tiago Cordeiro Felismino, et al. · Brazilian Journal of Oncology
Works count: 27
Citation count: 55
H-index: 4
I10-index: 2
Year
Topic
Type